Multicenter, Open-label Trial to Evaluate the Safety and Tolerability of Intravenous Eravacycline in Children From 8 Years to Less Than 18 Years of Age With Complicated Intra-abdominal Infections (cIAI)
Latest Information Update: 03 Feb 2025
Price :
$35 *
At a glance
- Drugs Eravacycline (Primary)
- Indications Appendicitis; Cholecystitis; Gastric perforation; Intestinal perforation; Intra-abdominal infections; Liver abscess; Peritonitis
- Focus Adverse reactions
- Sponsors Innoviva Specialty Therapeutics
- 03 Feb 2025 New trial record